{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:05:47Z","timestamp":1770746747611,"version":"3.49.0"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>There is a lack of information regarding the need to postpone conception after COVID-19 vaccination.<\/jats:p><\/jats:sec>Objective<\/jats:title>To investigate the time interval between the first dose of inactivated COVID-19 vaccine and in vitro fertilization (IVF) treatment as well as the rate of pregnancy after a fresh embryo transfer.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cohort study was conducted at a single public IVF center in China. Female patients aged 20 to 47 years and undergoing IVF treatment were consecutively registered from May 1 to December 22, 2021, with follow-up until March 31, 2022. Patients with SARS-CoV-2 infection before or during IVF treatment and those who underwent 2 or more IVF treatments, received the noninactivated or unknown COVID-19 vaccine, or did not have a fresh embryo transfer were excluded from this study.<\/jats:p><\/jats:sec>Exposures<\/jats:title>The vaccinated group (subdivided into 4 subgroups of time interval from first vaccination to fertilization treatment: \u226430 days, 31-60 days, 61-90 days, and \u226591 days) and nonvaccinated group.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Risk ratios (RRs) for the association between the time interval and ongoing pregnancy (pregnancy continued at least 12 weeks).<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 3052 female patients (mean [SD] age, 31.45 [3.96] years) undergoing IVF treatment were analyzed in this study. There were 667 vaccinated patients receiving IVF (35 were vaccinated \u226430 days, 58 were vaccinated 31-60 days, 105 were vaccinated 61-90 days, and 469 were vaccinated \u226591 days before fertilization treatment), and 2385 unvaccinated patients receiving treatment. The ovarian stimulation and laboratory parameters were similar among all groups. Ongoing pregnancy was significantly lower in the 30 days or less subgroup (34.3% [12 of 35]; adjusted RR [aRR], 0.61; 95% CI, 0.33-0.91) and the 31 to 60 days\u2019 subgroup (36.2% [21 of 58]; aRR, 0.63; 95% CI, 0.42-0.85). A slightly but not statistically lower rate was found in the 61 to 90 days\u2019 subgroup, and no reduced risk for ongoing pregnancy in the 91 days or more subgroup was observed (56.3% [264 of 469]; aRR, 0.96; 95% CI, 0.88-1.04) compared with the unvaccinated group (60.3% [1439 of 2385], as reference).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>Findings of this study suggest that receipt of the first inactivated COVID-19 vaccine dose 60 days or less before fertilization treatment is associated with a reduced rate of pregnancy. In patients undergoing IVF treatment with a fresh embryo transfer, the procedure may need to be delayed until at least 61 days after COVID-19 vaccination.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.36609","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T15:34:15Z","timestamp":1665761655000},"page":"e2236609","source":"Crossref","is-referenced-by-count":27,"title":["Association Between Time Interval from COVID-19 Vaccination to In Vitro Fertilization and Pregnancy Rate After Fresh Embryo Transfer"],"prefix":"10.1001","volume":"5","author":[{"given":"Wenhao","family":"Shi","sequence":"first","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Xue","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanzi","family":"Shi","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"issue":"4","key":"zoi221037r4","first-page":"296","article-title":"COVID-19 vaccination strategy for planning pregnancy and assisted reproductive technology treatment: expert recommendations","volume":"41","author":"Expert Group for Beijing Human Assisted Reproductive Technology Center for Quality Control and Improvement","year":"2021","journal-title":"Chin J Reprod Contracep"},{"issue":"9","key":"zoi221037r5","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1093\/humrep\/deab182","article-title":"Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination.","volume":"36","author":"Bentov","year":"2021","journal-title":"Hum Reprod"},{"issue":"3","key":"zoi221037r6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/humrep\/deab282","article-title":"The effect of Covid-19 mRNA vaccine on serum anti-M\u00fcllerian hormone levels.","volume":"37","author":"Mohr-Sasson","year":"2022","journal-title":"Hum Reprod"},{"issue":"8","key":"zoi221037r7","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s10815-022-02543-8","article-title":"Effects of COVID-19 vaccination status, vaccine type, and vaccination interval on IVF pregnancy outcomes in infertile couples.","volume":"39","author":"Dong","year":"2022","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"zoi221037r8","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.fertnstert.2022.02.025","article-title":"Coronavirus disease 2019 vaccination and infertility treatment outcomes.","volume":"117","author":"Avraham","year":"2022","journal-title":"Fertil Steril"},{"issue":"5","key":"zoi221037r9","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.fertnstert.2022.01.009","article-title":"The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome.","volume":"117","author":"Aizer","year":"2022","journal-title":"Fertil Steril"},{"key":"zoi221037r10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.840109","article-title":"Are the follicular fluid characteristics of recovered Coronavirus disease 2019 patients different from those of vaccinated women approaching in vitro fertilization?","volume":"13","author":"Castiglione Morelli","year":"2022","journal-title":"Front Physiol"},{"issue":"20","key":"zoi221037r11","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"zoi221037r12","doi-asserted-by":"publisher","first-page":"654.e1","DOI":"10.1016\/j.ajog.2021.06.101","article-title":"Blastocyst morphology is associated with the incidence of monozygotic twinning in assisted reproductive technology.","volume":"225","author":"Shi","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"zoi221037r13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.rbmo.2018.12.031","article-title":"Comparison of perinatal outcomes following blastocyst and cleavage-stage embryo transfer: analysis of 10 years\u2019 data from a single centre.","volume":"38","author":"Shi","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"zoi221037r14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fendo.2019.00409","article-title":"Cumulative live birth rates of good and low prognosis patients according to POSEIDON criteria: a single center analysis of 18,455 treatment cycles.","volume":"10","author":"Shi","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"zoi221037r15","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","article-title":"Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer.","volume":"73","author":"Gardner","year":"2000","journal-title":"Fertil Steril"},{"issue":"1","key":"zoi221037r16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12958-021-00757-6","article-title":"Does mRNA SARS-CoV-2 vaccine influence patients\u2019 performance during IVF-ET cycle?","volume":"19","author":"Orvieto","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"zoi221037r17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/AOG.0000000000004713","article-title":"In vitro fertilization and early pregnancy outcomes after Coronavirus disease 2019 (COVID-19) vaccination.","volume":"139","author":"Aharon","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"5","key":"zoi221037r18","doi-asserted-by":"publisher","DOI":"10.1111\/aji.v87.5","article-title":"Does mRNA SARS-CoV-2 vaccine in the follicular fluid impact follicle and oocyte performance in IVF treatments?","volume":"87","author":"Odeh-Natour","year":"2022","journal-title":"Am J Reprod Immunol"},{"key":"zoi221037r19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/JIR.S347729","article-title":"No effect of inactivated SARS-CoV-2 vaccination on in vitro fertilization outcomes: a propensity score-matched study.","volume":"15","author":"Huang","year":"2022","journal-title":"J Inflamm Res"},{"issue":"10","key":"zoi221037r20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/09513590.2021.1918080","article-title":"Does COVID-19 infection influence patients\u2019 performance during IVF-ET cycle? an observational study.","volume":"37","author":"Orvieto","year":"2021","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"zoi221037r21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/humrep\/deac043","article-title":"IVF under COVID-19: treatment outcomes of fresh ART cycles.","volume":"37","author":"Youngster","year":"2022","journal-title":"Hum Reprod"},{"issue":"9","key":"zoi221037r22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/medicina57090946","article-title":"The impact of SARS-CoV-2 on sperm cryostorage, theoretical or real risk?","volume":"57","author":"Anifandis","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"zoi221037r1","unstructured":"ASRM COVID-19 Task Force. ASRM patient management and clinical recommendations during the Coronavirus (COVID-19) pandemic. ASRM Bulletin. April 20, 2022. Accessed September 9, 2022. https:\/\/www.asrm.org\/news-and-publications\/news-and-research\/press-releases-and-bulletins\/asrm-covd-19-task-force-issues-update-no.-20\/"},{"key":"zoi221037r2","unstructured":"Centers for Disease Control and Prevention. Planning for pregnancy: COVID-19 vaccines for people who would like to have a baby. Accessed September 9, 2022. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/planning-for-pregnancy.html#print"},{"key":"zoi221037r3","unstructured":"European Society of Human Reproduction and Embryology COVID-19 Working Group. COVID-19 vaccination and assisted reproduction. January 12, 2021. Accessed September 9, 2022. https:\/\/www.eshre.eu\/-\/media\/sitecore-files\/Position-statements\/COVID19-vaccination-and-assisted-reproduction_18022021.pdf?la=en&hash=D9AC5E9D015D6C954308A5CA7D425AC9CBA63673"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2797318\/shi_2022_oi_221037_1664988094.5842.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T15:34:23Z","timestamp":1665761663000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2797318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.36609","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]}}}